Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
30 November 2021Website:
http://www.cero.bioNext earnings report:
N/ALast dividends:
N/ANext dividends:
N/APrice
after hours | Wed, 03 Jul 2024 20:59:28 GMTDividend
Analysts recommendations
Institutional Ownership
What type of business is CERo Therapeutics Holdings?
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.
What sector is CERo Therapeutics Holdings in?
CERo Therapeutics Holdings is in the Healthcare sector
What industry is CERo Therapeutics Holdings in?
CERo Therapeutics Holdings is in the Biotechnology industry
What country is CERo Therapeutics Holdings from?
CERo Therapeutics Holdings is headquartered in United States
When did CERo Therapeutics Holdings go public?
CERo Therapeutics Holdings initial public offering (IPO) was on 30 November 2021
What is CERo Therapeutics Holdings website?
https://www.cero.bio
Is CERo Therapeutics Holdings in the S&P 500?
No, CERo Therapeutics Holdings is not included in the S&P 500 index
Is CERo Therapeutics Holdings in the NASDAQ 100?
No, CERo Therapeutics Holdings is not included in the NASDAQ 100 index
Is CERo Therapeutics Holdings in the Dow Jones?
No, CERo Therapeutics Holdings is not included in the Dow Jones index
When does CERo Therapeutics Holdings report earnings?
Next earnings report date is not announced yet